medical-technology
Meniscus prosthesis receives €2.5 million EU grant
The Dutch startup is working on the first anatomical meniscus prostheses for patients with chronic knee pain.
News
medical-technology
New isolation unit for highly infectious patient
The new isolation ward at Radboudumc in the Netherlands is the most advanced unit of its kind in Europe.
medical-technology
Liver tumors irradiated from inside can be followed live from outside
A Dutch research team from Radboud University Medical Center has visualized the injection of radioactive microspheres during treatment of a patient with liver tumors ‘live on screen’.
medical-technology
Talks and games: Enzyre introduces students to the world of innovation and health
On January 18, Enzyre organized an informative day on the Novio Tech Campus for medicine and molecular life sciences students of Radboud University, we spoke to the students to find out what they learned.
medical-technology
Plasmacure: Curing chronic wounds with air and electricity
Founder Bas Zeper has been working on Plasmacure since 2014, to make a difference for people suffering from chronic wounds. Together with CMO Koen Lim, he now faces the final hurdle: convincing doctors, hospitals, and insurance companies of the benefits of their product PLASOMA.
medical-technology
Digital biomarkers show doctor how you are really doing
With digital biomarkers, you can measure health more objectively. This gives doctors a better picture of a patient. The Nijmegen-based company Orikami develops such biomarkers for practical use, including in cooperation with Radboudumc and Radboud University.
medical-technology
Tessa’s algorithms will help millions with dementia maintain autonomy
Wang Long Li wants to contribute to healthcare. Not as a doctor, but with tools that are perfectly tailored to clients’ needs. That’s why he founded Tinybots, and designed robot Tessa.
medical-technology
T-Guard can reset immune system
For 20 years, Nijmegen-based Xenikos has been working on a drug that can reset the immune system. It is now make or break for their drug T-Guard.
12
